TNDM
Tandem Diabetes Care, Inc.NASDAQHealthcare$18.61-1.06%ClosedMarket Cap: $1.27B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
8.40
P/S
1.29
EV/EBITDA
-10.22
DCF Value
$-45.12
FCF Yield
-2.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
53.8%
Operating Margin
-18.2%
Net Margin
-20.2%
ROE
-142.0%
ROA
-23.2%
ROIC
-27.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $290.4M | 57.7% | $8.3M | $-589.0K | $-0.01 | — |
| FY 2025 | $1.01B | 52.3% | $-78.1M | $-204.7M | $-3.04 | — |
| Q3 2025 | $249.3M | 53.9% | $-20.1M | $-21.2M | $-0.31 | — |
| Q2 2025 | $240.7M | 52.3% | $-51.8M | $-52.4M | $-0.78 | — |
| Q1 2025 | $234.4M | 50.5% | $-120.9M | $-130.6M | $-1.97 | — |
| Q4 2024 | $282.6M | 55.7% | $-582.0K | $755.0K | $0.01 | — |
| FY 2024 | $940.2M | 52.1% | $-99.1M | $-96.0M | $-1.47 | — |
| Q3 2024 | $363.3M | 34.3% | $-26.1M | $-23.3M | $-0.35 | — |
| Q2 2024 | $221.9M | 50.8% | $-30.8M | $-30.8M | $-0.47 | — |
| Q1 2024 | $191.7M | 49.4% | $-41.7M | $-42.7M | $-0.65 | — |
| Q4 2023 | $196.8M | 47.4% | $-35.1M | $-30.0M | $-0.46 | — |
| FY 2023 | $747.7M | 49.2% | $-233.2M | $-222.6M | $-3.43 | — |